Unoccupied prolactin binding components of the benign and malignant human prostate in a subclinical and clinical procedure
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 16 (5) , 461-467
- https://doi.org/10.1016/0883-2897(89)90056-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Prognostic significance of prolactin receptors (PRL-R) in human breast cancerJournal of Steroid Biochemistry, 1987
- Carcinoma of the prostate: Relationship of pretreatment hormone levels to survivalEuropean Journal of Cancer and Clinical Oncology, 1984
- Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: Can estrogen treatment increase androgen receptor content?The Journal of Steroid Biochemistry and Molecular Biology, 1983
- Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer:Relation to therapeutic responseCancer, 1982
- Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostateCancer, 1979
- Prolactin and prostate cancerUrology, 1977
- Control of growth of mammalian cells in cell cultureNature, 1975
- A graphic method for the determination and presentation of binding parameters in a complex systemAnalytical Biochemistry, 1967
- Occult Prostatic Carcinoma Diagnosed by the Step-section Technique of the Surgical SpecimenJournal of Urology, 1965